We’d love to hear your feedback on this activity. It helps us to continually improve our products.
There is still extensive ongoing research, however CAR-T technology for lung cancer is providing much promise but many challenges. touchONCOLOGY spoke to Dr Prasad S Adusumilli (Memorial Sloan-Kettering Cancer Center, New York, NY, USA) to discuss the potential of CAR-T therapy in lung cancer and the recent breakthroughs in this area. Questions […]
“The tissue is the issue” was a strong theme of the 2013 CAP/IASLC/AMP guidelines. touchONCOLOGY spoke to Professor Fred Hirsch (The Mount Sinai Hospital, New York City, NY, USA) to discuss his presentation at the European Lung Cancer Congress 2022, providing an update on the current state of personalized medicine and molecular testing in lung […]
Molecular testing is important to selecting patients with advanced non-small cell lung cancer (NSCLC) who may benefit from targeted therapy or immunotherapy. touchONCOLOGY spoke to Professor Fred Hirsch (The Mount Sinai Hospital, New York City, NY, USA) to discuss his presentation at the European Lung Cancer Congress 2022, providing an update on the current state of […]
Non-small cell lung cancer (NSCLC) shows the success of personalized medicine in treating solid tumors. touchONCOLOGY spoke to Professor Fred Hirsch (The Mount Sinai Hospital, New York City, NY, USA) to discuss his presentation at the European Lung Cancer Congress 2022, providing an update on the current state of personalized medicine and molecular testing in lung […]
Biomarker testing is important for determining the the best treatment for patients newly diagnosed with NSCLC. touchONCOLOGY spoke to Professor Fred Hirsch (The Mount Sinai Hospital, New York City, NY, USA) to discuss his presentation at the European Lung Cancer Congress 2022, providing an update on the current state of personalized medicine and molecular testing in […]
touchONCOLOGY spoke to Dr Lizza Hendriks (Maastricht University, The Netherlands) to discuss her presentation at the European Lung Cancer Congress 2022, providing an update on the use of immunotherapy for the treatment for non-oncogene addicted non-small cell lung cancer with brain metastases. Questions Could you give us a brief overview of current […]
Professor Carmelo Rizzari, President of the European Society of Paediatric Oncology (SIOP Europe), explains who the Annual Meeting is aimed at, who is involved and what were the main take-away messages from this year’s conference. Questions Who were the participants of the SIOPE Annual Meeting? (01:00-02:29) What is the main message you wish to share […]
We were delighted to catch up with Dr. Bart Westerman (VU Medical Center, Amsterdam UMC, Amsterdam, The Netherlands) to discuss his presentation entitled ‘An AI Model Can Help Predict Adverse Events From New Drug Combinations’, which was presented at AACR 2022, 8-13 April 2022. Questions Why is it important to better predict the benefit-risk profile […]
It was a pleasure to speak with Professor Carmelo Rizzari, President of the European Society of Paediatric Oncology (SIOP Europe), who explained why the concept of the SIOP Europe Annual Meeting is different to other scientific congresses. Speaker Disclosure: Speaker Disclosure: Carmelo Rizzari has been a consultant for Jazz Pharmaceutcials, Amgen, Servier and Clinigen. He […]
Get the latest clinical insights from touchONCOLOGY